about
Chronic neutrophilic leukemia: a clinical perspectiveNew mutations in chronic lymphocytic leukemia identified by target enrichment and deep sequencingAbrogation of RUNX1 gene expression in de novo myelodysplastic syndrome with t(4;21)(q21;q22).ASXL1, TP53 and IKZF3 mutations are present in the chronic phase and blast crisis of chronic myeloid leukemia.CSF3R T618I co-occurs with mutations of splicing and epigenetic genes and with a new PIM3 truncated fusion gene in chronic neutrophilic leukemia.Cap-independent translation ensures mTOR expression and function upon protein synthesis inhibition.More than just scanning: the importance of cap-independent mRNA translation initiation for cellular stress response and cancer.The role of alternative splicing coupled to nonsense-mediated mRNA decay in human disease.PROS1 novel splice-site variant decreases protein S expression in patients from two families with thrombotic disease.eIF3: a factor for human health and disease.Clinical relevance of FLT3 gene abnormalities in Brazilian patients with infant leukemia.Exome sequencing reveals novel and recurrent mutations with clinical impact in blastic plasmacytoid dendritic cell neoplasmNebulette is the second member of the nebulin family fused to the MLL gene in infant leukemiaMyeloid neoplasms with der(1)t(1;19) may constitute a specific entity characterized by a cytogenetic biomarker and gene mutations involved in DNA methylationAlternative Mechanisms of mRNA Translation Initiation in Cellular Stress Response and CancerExperimental supporting data on DIS3L2 over nonsense-mediated mRNA decay targets in human cellsA role for DIS3L2 over natural nonsense-mediated mRNA decay targets in human cells
P50
Q26781167-99972685-45DF-4BB2-A933-3C1BDB5C08DAQ30466798-F6B199BE-A523-4C35-A28A-FD9DEC3AC6D0Q33398370-BBB4039C-CE17-496A-AB20-4699B9EA2CD7Q37431986-8B8D8A13-AF47-4DF5-ADA1-8302A3CA6EA3Q37431993-C642CED7-21C5-462E-9581-177F1B003AFEQ38618035-CF29A7AD-7924-4BEA-8E2C-9247B0C4D3ADQ39028088-7A560607-83AD-4F3B-82B2-C6821425BD90Q39458148-5FAC71BC-352A-4EA3-943A-B1B335420F71Q47116293-939297FD-510C-4570-8398-C255C8FCD677Q52445969-890E279F-AAB4-4D36-A435-72756B6811D5Q54783689-63BCED2F-8B29-431D-9C54-60AE24A52C4BQ58010082-AE60520A-BCA6-493C-B7ED-D643039E7CFAQ58492951-3A0539EC-1F82-457B-B248-519EFAC95F97Q87454552-D01B195F-6B27-4F39-B8D3-4E8BD11D0A4BQ92162437-03BB3DD0-7597-4F57-BFA7-6A7CB51F1FF4Q92314804-139EADB1-F7F6-44B5-9DC9-996039F1403DQ92990690-09D5B049-0D57-4072-98DD-2DE8CFDF44CC
P50
description
researcher, ORCID id # 0000-0003-3727-2096
@en
wetenschapper
@nl
name
Juliane Menezes
@ast
Juliane Menezes
@en
Juliane Menezes
@es
Juliane Menezes
@nl
type
label
Juliane Menezes
@ast
Juliane Menezes
@en
Juliane Menezes
@es
Juliane Menezes
@nl
prefLabel
Juliane Menezes
@ast
Juliane Menezes
@en
Juliane Menezes
@es
Juliane Menezes
@nl
P106
P31
P496
0000-0003-3727-2096